It was reported that a patient underwent an eventrorraphy procedure on (b)(6) 2020 and the mesh was implanted.
It was reported that on (b)(6) 2020, the patient reported feeling well, with controlled pain, no fever, no emesis, satisfactory evolution.
It was also reported that on (b)(6) 2020, the patient indicated that she had pain after surgical intervention associated with heat, redness and erythema, the day before she removed the drain.
It was also reported that the patient had new paraclinics performed with pcr 22.
26, hb: 10.
4, platelets: 516000.
It was reported that antibiotic treatment was started with cefazolin 2 g / 6 hours, tramadol 50 mg / 8 h, dipyrone 1 g / 8 h.
It was reported that on 7/5/2020 the patient continued with the same management.
It was reported that a review by a surgeon on (b)(6) 2020 indicated iso, with improvement in pain and heat, and collection was discarded.
It was reported that enoxaparin 40 mg / sc / day was added.
It was also reported that on (b)(6) 2020 a review by a surgeon indicated no peritoneal irritation, surgical wound in good condition, no secretions or bleeding.
It was reported that with symptomatic and clinical improvement patient was given recommendations, warning signs, order of oral antibiotic, discharge and control appointment.
(cephalexin 500 mg / 6 hours for 5 days).
|